Navigation Links
New drugs for resistant forms of TB

An international meeting on breathing disorders in Paris discussed the ongoing research on development of new drugs against tuberculosis. //There is a need to revamp the more than a century old test that takes a long time for detection and drugs to which the strains of TB have become resistant.

According to Nils Billo, one of the organisers of the 37th world congress of the Union for breathing health and executive director of the Paris-based International Union Against Tuberculosis and Breathing Disorders (UNION), 2 new methods of development of new drugs against TB are being discussed.

"During the Paris conference, we will witness the presentation of the research work conducted by two teams. The response we get from these works is that which sustains the hope of getting new drugs against the disease in the next few years," Billo said.

The multi-drug resistant TB that is resistant to the antibiotics isoniazid and rifampin has been a major cause of concern to the health officials for more than a decade.

He said, "The new drugs, if developed, would take into account the resistance of tuberculosis to the already existing antibiotics, their prices would be affordable even in developing countries."

"The making of new drugs will arguably be a decisive element in the fight against TB but this fight could be won only if southern countries have significant human resources on the fight against tuberculosis," Billo said.

Tuberculosis is the world's deadliest curable infectious respiratory disease that spreads by coughing and sneezing. According to the World Health Organization, it claims 1.7 million lives every year.

Asthma and tobacco addiction will also be discussed in the conference attended by over 2,000 participants from 130 countries.
GYT
'"/>




Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
3. African HIV strains more resistant to anti HIV drugs
4. Right drugs drastically cut stroke risk
5. Relating heart protection and antihypertensive drugs
6. Enzyme may be target for obesity drugs
7. New HIV cases resist drugs
8. Relief to pregnant women using fertility drugs
9. AIDS drugs linked to heart attack risk
10. FDA debates status of decongestant drugs
11. Status of some prescription drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... Delta ... $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently retired as ... was the American Cancer Society’s 2015 CEO of the Year , helped lead ...
(Date:2/8/2016)... ... ... Discover the Rocky Mountain region’s longest running and impressive garden and home show where ... see the most incredible gardens and home improvement experts that attend this amazing show. ... - 700 14th St. Denver CO, is an exciting event that Performance Mobility has ...
(Date:2/8/2016)... ... , ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal ... birthday on February 10th. During this time, people can achieve better health, greater ... people from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
(Date:2/7/2016)... Dallas, Texas (PRWEB) , ... February 07, 2016 ... ... its new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and ... , MyDecision™ combines three elements to cut the cost of providing employee healthcare ...
(Date:2/6/2016)... (PRWEB) , ... February 06, 2016 , ... Shark ... to announce the launch of a new DRTV campaign with Belly Bands. , Having ... tried everything from sprays to puppy pads and find nothing works, get Belly ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
(Date:2/8/2016)... Feb. 8, 2016 Palatin Technologies, Inc. ... receptor-specific peptide therapeutics for the treatment of diseases ... announced today that the United States Patent and ... Allowance for U.S. Patent Application Serial Number 14/313,258 ... methods of treating female sexual dysfunction using the ...
(Date:2/5/2016)... , Feb. 5, 2016 Amgen (NASDAQ: AMGN ... Annual Global Healthcare Conference at 9:15 a.m. ET on Wednesday, ... . David W. Meline , executive vice president and ... Live audio of the presentation can be accessed from the ... A replay of the webcast will also be available on ...
Breaking Medicine Technology: